José Somocurcio-Peralta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
José Somocurcio-Peralta has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- José Paz-Ibarra
Universidad Nacional Mayor de San Marcos
5 shared publications - Juan Eduardo Quiroz-Aldave
Hospital de apoyo Chepén
4 shared publications - Marcio José Concepción-Zavaleta
Universidad Científica del Sur
4 shared publications - Julio César Alvarez-Gamero
Division of Endocrinology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
3 shared publications - Carmen E. Yagui Uku
Hospital Nacional Daniel A. Carrión, Callao, Perú
2 shared publications - Jacsel Suarez-Rojas
Carrera de Medicina Humana, Universidad Científica del Sur, Lima, Peru
2 shared publications
Latest Publications
- Open Access
- 19 January 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1)
Sarcoma sinovial pleuropulmonar: reporte de una entidad inusual en un hospital peruano
Primary pulmonary synovial sarcoma (SS) is a tumor derived from pluripotential mesenchymal cells. It accounts for 0.1-0.5% of all pulmonary tumors and typically occurs in young, non-smoking individuals, classified according to the cellular pattern as monophasic or biphasic. Intrathoracic involvement can occur in various locations, including the pleuropulmonary region, mediastinum, thoracic wall, trachea, and diaphragm. Diagnosis is challenging and treatment includes surgery, chemotherapy, and radiotherapy. We present the case of a 65-year-old male patient with no smoking history who was admitted due to progressive dyspnea, chest pain, and weight loss. Thoracic computed tomography revealed moderate pleural effusion associated with a heterogeneous mass in the left hemithorax. Histopathology of the tissue obtained by percutaneous biopsy reported a primarily monophasic synovial sarcoma. Palliative treatment with serial pleural drainage, chemical pleurodesis, and pain management was indicated. The patient passed away 10 months after the onset of symptoms.
- 19 January 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1)
Open AccessSarcoma sinovial pleuropulmonar: reporte de una entidad inusual en un hospital peruano
Primary pulmonary synovial sarcoma (SS) is a tumor derived from pluripotential mesenchymal cells. It accounts for 0.1-0.5% of all pulmonary tumors and typically occurs in young, non-smoking individuals, classified according to the cellular pattern as monophasic or biphasic. Intrathoracic involvement can occur in various locations, including the pleuropulmonary region, mediastinum, thoracic wall, trachea, and diaphragm. Diagnosis is challenging and treatment includes surgery, chemotherapy, and radiotherapy. We present the case of a 65-year-old male patient with no smoking history who was admitted due to progressive dyspnea, chest pain, and weight loss. Thoracic computed tomography revealed moderate pleural effusion associated with a heterogeneous mass in the left hemithorax. Histopathology of the tissue obtained by percutaneous biopsy reported a primarily monophasic synovial sarcoma. Palliative treatment with serial pleural drainage, chemical pleurodesis, and pain management was indicated. The patient passed away 10 months after the onset of symptoms.
- Open Access
- 1 January 2026
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2026 (1)
Papillary thyroid carcinoma in thyroglossal duct cyst: a Peruvian case series
Summary: Papillary thyroid carcinoma (PTC) is the most frequent type of differentiated thyroid cancer, while thyroglossal duct cysts (TGDCs) are common congenital anomalies of the neck. The coexistence of PTC within a TGDC is exceptionally rare, with a reported incidence of less than 1.5%. We present three Peruvian cases of PTC arising in TGDCs. The patients (two females and one male; age range: 34–47 years) presented with progressive midline cervical masses of two to four years’ duration. All underwent cervical ultrasound, contrast-enhanced computed tomography, and fine-needle aspiration biopsy. Histopathology confirmed PTC, including classical and follicular variants. Surgical management varied: two patients underwent Sistrunk procedure alone, while one required Sistrunk surgery followed by total thyroidectomy, cervical lymph node dissection, and radioactive iodine (RAI) therapy. All patients remain disease-free after 6–12 years of follow-up. The diagnosis of carcinoma in TGDC is often incidental, but preoperative imaging and cytology can raise suspicion. Optimal management remains controversial; while the Sistrunk procedure may be sufficient in most cases of PTC confined to TGDC without extracapsular extension, in some scenarios, such as the presence of suspicious thyroid nodules, extracystic extension, and cervical lymph node metastasis, an additional thyroidectomy and RAI therapy may be warranted. In conclusion, PTC in TGDC is a rare entity with generally favorable prognosis. Early recognition, individualized treatment, and multidisciplinary decision-making are essential for optimal outcomes. Learning points:
- 1 January 2026
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2026 (1)
Open AccessPapillary thyroid carcinoma in thyroglossal duct cyst: a Peruvian case series
Summary: Papillary thyroid carcinoma (PTC) is the most frequent type of differentiated thyroid cancer, while thyroglossal duct cysts (TGDCs) are common congenital anomalies of the neck. The coexistence of PTC within a TGDC is exceptionally rare, with a reported incidence of less than 1.5%. We present three Peruvian cases of PTC arising in TGDCs. The patients (two females and one male; age range: 34–47 years) presented with progressive midline cervical masses of two to four years’ duration. All underwent cervical ultrasound, contrast-enhanced computed tomography, and fine-needle aspiration biopsy. Histopathology confirmed PTC, including classical and follicular variants. Surgical management varied: two patients underwent Sistrunk procedure alone, while one required Sistrunk surgery followed by total thyroidectomy, cervical lymph node dissection, and radioactive iodine (RAI) therapy. All patients remain disease-free after 6–12 years of follow-up. The diagnosis of carcinoma in TGDC is often incidental, but preoperative imaging and cytology can raise suspicion. Optimal management remains controversial; while the Sistrunk procedure may be sufficient in most cases of PTC confined to TGDC without extracapsular extension, in some scenarios, such as the presence of suspicious thyroid nodules, extracystic extension, and cervical lymph node metastasis, an additional thyroidectomy and RAI therapy may be warranted. In conclusion, PTC in TGDC is a rare entity with generally favorable prognosis. Early recognition, individualized treatment, and multidisciplinary decision-making are essential for optimal outcomes. Learning points:
- Open Access
- 7 June 2025
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 18 (2) , e2715
Functioning adrenocortical carcinoma: a peruvian case series
Introduction: Adrenocortical carcinoma (ACC), the second most common malignant endocrine tumor, arises from the adrenal cortex and is primarily diagnosed in middle-aged individuals. Functioning ACC often presents with hyperandrogenism, with or without hypercortisolism. Approximately 50% of cases are functioning. Case report: We present the cases of two adult women who exhibited hyperandrogenism and a giant abdominal mass on physical examination. The diagnosis of ACC was confirmed through histopathological analysis. Discussion: Functioning ACC typically presents with a large abdominal mass and elevated adrenal hormone levels. Diagnosis involves hormonal testing and imaging studies. CT imaging is essential for the initial assessment of ACC, as it can detect features such as mass heterogeneity, and assess potential infiltration. Treatment generally involves surgical resection for localized tumors or chemotherapy for advanced cases. Survival rates decrease in advanced stages and with larger tumor sizes. Conclusion: ACC should be considered in the differential diagnosis of abdominal masses accompanied by hyperandrogenism.
- 7 June 2025
- Published by Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo in Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
- Vol. 18 (2) , e2715
Open AccessFunctioning adrenocortical carcinoma: a peruvian case series
Introduction: Adrenocortical carcinoma (ACC), the second most common malignant endocrine tumor, arises from the adrenal cortex and is primarily diagnosed in middle-aged individuals. Functioning ACC often presents with hyperandrogenism, with or without hypercortisolism. Approximately 50% of cases are functioning. Case report: We present the cases of two adult women who exhibited hyperandrogenism and a giant abdominal mass on physical examination. The diagnosis of ACC was confirmed through histopathological analysis. Discussion: Functioning ACC typically presents with a large abdominal mass and elevated adrenal hormone levels. Diagnosis involves hormonal testing and imaging studies. CT imaging is essential for the initial assessment of ACC, as it can detect features such as mass heterogeneity, and assess potential infiltration. Treatment generally involves surgical resection for localized tumors or chemotherapy for advanced cases. Survival rates decrease in advanced stages and with larger tumor sizes. Conclusion: ACC should be considered in the differential diagnosis of abdominal masses accompanied by hyperandrogenism.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 25 (4) , 344-348
Calcitonin-producing Duodenal Neuroendocrine Tumor: A Case Report and Literature Review
Introduction: Neuroendocrine tumors (NETs) exhibit a wide range of clinical presentations, including the production of various hormones. Calcitonin, a sensitive marker for medullary thyroid cancer (MTC), is nonspecific and may be elevated in extra-thyroidal NETs. Case Report: We present the case of a 64-year-old female patient who underwent total thyroidectomy due to a nodule in the isthmus, with a fine-needle aspiration biopsy indicating follicular neoplasia. Pathological examination revealed macro- and micro-nodular thyroid hyperplasia, along with a parathyroid adenoma. During postoperative follow-up, a progressive elevation of calcitonin was observed, reaching 64.2 pg/ml, while carcinoembryonic antigen levels remained normal. Since no MTC foci were found upon reviewing the thyroidectomy specimen, an investigation into the origin of the elevated calcitonin was initiated. Serum chromogranin A and specific neuronal enolase levels were within normal ranges. Tc-99m HYNICTOC scintigraphy yielded negative results. Additionally, an upper gastrointestinal endoscopy revealed a submucosal lesion in the second portion of the duodenum, with a biopsy confirming a grade 1 NET. The patient underwent Whipple surgery and hepatic metastasectomy. Postoperatively, a decrease in baseline serum calcitonin levels was observed. Seven years after surgery, she continues specialized monitoring with no biochemical or imaging evidence of disease. Conclusion: Serum calcitonin contributes to the diagnosis and monitoring of anterior intestine NETs.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 25 (4) , 344-348
Calcitonin-producing Duodenal Neuroendocrine Tumor: A Case Report and Literature Review
Introduction: Neuroendocrine tumors (NETs) exhibit a wide range of clinical presentations, including the production of various hormones. Calcitonin, a sensitive marker for medullary thyroid cancer (MTC), is nonspecific and may be elevated in extra-thyroidal NETs. Case Report: We present the case of a 64-year-old female patient who underwent total thyroidectomy due to a nodule in the isthmus, with a fine-needle aspiration biopsy indicating follicular neoplasia. Pathological examination revealed macro- and micro-nodular thyroid hyperplasia, along with a parathyroid adenoma. During postoperative follow-up, a progressive elevation of calcitonin was observed, reaching 64.2 pg/ml, while carcinoembryonic antigen levels remained normal. Since no MTC foci were found upon reviewing the thyroidectomy specimen, an investigation into the origin of the elevated calcitonin was initiated. Serum chromogranin A and specific neuronal enolase levels were within normal ranges. Tc-99m HYNICTOC scintigraphy yielded negative results. Additionally, an upper gastrointestinal endoscopy revealed a submucosal lesion in the second portion of the duodenum, with a biopsy confirming a grade 1 NET. The patient underwent Whipple surgery and hepatic metastasectomy. Postoperatively, a decrease in baseline serum calcitonin levels was observed. Seven years after surgery, she continues specialized monitoring with no biochemical or imaging evidence of disease. Conclusion: Serum calcitonin contributes to the diagnosis and monitoring of anterior intestine NETs.
- Open Access
- 31 December 2024
- Published by Colegio Medico del Peru in ACTA MEDICA PERUANA
- Vol. 41 (4) , 286-291
Criptococosis pulmonar en una paciente con artritis reumatoide en la era COVID: reporte de caso
La criptococosis pulmonar (CP) afecta principalmente, aunque no exclusivamente, a personas inmunosuprimidas. La clínica es variable y el diagnóstico un reto, siendo los principales diagnósticos diferenciales la tuberculosis y el cáncer. Debido al neurotropismo de este microorganismo, el estudio del líquido cefalorraquídeo (LCR) es obligatorio. El tratamiento depende de la severidad y extensión de la enfermedad, así como el estado inmune del paciente. Presentamos el caso de una paciente de 74 años con artritis reumatoide en tratamiento con prednisona, leflunomida y metotrexato que, posterior al diagnóstico de COVID-19 leve, 6 meses antes de su ingreso, cursó con dolor torácico, tos productiva y disnea progresiva. La tomografía de tórax mostró consolidaciones pulmonares múltiples bilaterales. El estudio histológico del tejido obtenido mediante biopsia percutánea transtorácica fue compatible con criptococosis. La tinción de tinta china y el antígeno criptocócico (CrAg) fueron negativos en líquido cefalorraquídeo, mientras el CrAg sérico fue positivo. Se inició fluconazol vía oral con respuesta favorable.
- 31 December 2024
- Published by Colegio Medico del Peru in ACTA MEDICA PERUANA
- Vol. 41 (4) , 286-291
Open AccessCriptococosis pulmonar en una paciente con artritis reumatoide en la era COVID: reporte de caso
La criptococosis pulmonar (CP) afecta principalmente, aunque no exclusivamente, a personas inmunosuprimidas. La clínica es variable y el diagnóstico un reto, siendo los principales diagnósticos diferenciales la tuberculosis y el cáncer. Debido al neurotropismo de este microorganismo, el estudio del líquido cefalorraquídeo (LCR) es obligatorio. El tratamiento depende de la severidad y extensión de la enfermedad, así como el estado inmune del paciente. Presentamos el caso de una paciente de 74 años con artritis reumatoide en tratamiento con prednisona, leflunomida y metotrexato que, posterior al diagnóstico de COVID-19 leve, 6 meses antes de su ingreso, cursó con dolor torácico, tos productiva y disnea progresiva. La tomografía de tórax mostró consolidaciones pulmonares múltiples bilaterales. El estudio histológico del tejido obtenido mediante biopsia percutánea transtorácica fue compatible con criptococosis. La tinción de tinta china y el antígeno criptocócico (CrAg) fueron negativos en líquido cefalorraquídeo, mientras el CrAg sérico fue positivo. Se inició fluconazol vía oral con respuesta favorable.
- Open Access
- 6 November 2024
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 21 (6) , em611
Parathyroid apoplexy from giant adenoma with mediastinal extension: A case report
Introduction: Primary hyperparathyroidism (PHPT) results from an excess secretion of parathyroid hormone (PTH), primarily due to parathyroid adenomas. These adenomas are more prevalent in women and, although rare, can develop into giant adenomas. One infrequent but notable complication of giant adenomas is parathyroid apoplexy. The aim of this manuscript is to describe the case of a Peruvian female patient diagnosed with PHPT secondary to a giant parathyroid adenoma, whose surgical treatment confirmed its apoplexy. Case report: A 42-year-old Peruvian woman with hypertension and stage IV chronic kidney disease presented with a non-productive cough, dysphonia, and acute chest pain, revealing a mediastinal tumor on imaging. Physical examination showed no cervical tumors, and biochemical tests revealed elevated levels of total calcium and intact PTH, while serum phosphorus and calcitonin levels were normal. Imaging elucidated a parathyroid adenoma with mediastinal extension. Surgical intervention involved right parathyroidectomy, unveiling a 6 × 6 cm tumor with cystic and hemorrhagic degeneration, confirming the diagnosis of parathyroid apoplexy from a giant adenoma. Conclusions: Giant parathyroid adenoma should be considered in patients presenting with a mediastinal mass and hypercalcemia. This condition can be complicated by parathyroid apoplexy in the context of PHPT. Timely imaging and surgical intervention are crucial for achieving optimal outcomes, with diagnosis confirmed through histopathology.
- 6 November 2024
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 21 (6) , em611
Open AccessParathyroid apoplexy from giant adenoma with mediastinal extension: A case report
Introduction: Primary hyperparathyroidism (PHPT) results from an excess secretion of parathyroid hormone (PTH), primarily due to parathyroid adenomas. These adenomas are more prevalent in women and, although rare, can develop into giant adenomas. One infrequent but notable complication of giant adenomas is parathyroid apoplexy. The aim of this manuscript is to describe the case of a Peruvian female patient diagnosed with PHPT secondary to a giant parathyroid adenoma, whose surgical treatment confirmed its apoplexy. Case report: A 42-year-old Peruvian woman with hypertension and stage IV chronic kidney disease presented with a non-productive cough, dysphonia, and acute chest pain, revealing a mediastinal tumor on imaging. Physical examination showed no cervical tumors, and biochemical tests revealed elevated levels of total calcium and intact PTH, while serum phosphorus and calcitonin levels were normal. Imaging elucidated a parathyroid adenoma with mediastinal extension. Surgical intervention involved right parathyroidectomy, unveiling a 6 × 6 cm tumor with cystic and hemorrhagic degeneration, confirming the diagnosis of parathyroid apoplexy from a giant adenoma. Conclusions: Giant parathyroid adenoma should be considered in patients presenting with a mediastinal mass and hypercalcemia. This condition can be complicated by parathyroid apoplexy in the context of PHPT. Timely imaging and surgical intervention are crucial for achieving optimal outcomes, with diagnosis confirmed through histopathology.
- Open Access
- 29 April 2024
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 24 (2) , 172-36
Report of case of systemic al amyloidosis in a 65-year-old man with chronic diarrhea and hemolacria
The case of a 65-year-old male with chronic diarrhea, periorbital ecchymosis, and hemolacria is described. Laboratory studies, biopsy, and immunohistochemical analysis were performed to confirm the diagnosis. The dependent variable was the confirmed diagnosis of AL amyloidosis, while the independent variables included clinical symptoms and diagnostic test results. Descriptive techniques were used to analyze the clinical and laboratory data. The patient presented with chronic diarrhea unresponsive to conventional treatment, periorbital ecchymosis, and hemolacria. Diagnostic studies revealed amyloid deposits in the tissues. Immunohistochemical analysis confirmed systemic light chain AL amyloidosis. Specific treatment was initiated, partially improving the symptoms and stabilizing the patient's condition. Systemic AL amyloidosis requires a high index of clinical suspicion for timely diagnosis. The combination of diagnostic studies and early treatment can improve the prognosis of these patients.
- 29 April 2024
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 24 (2) , 172-36
Open AccessReport of case of systemic al amyloidosis in a 65-year-old man with chronic diarrhea and hemolacria
The case of a 65-year-old male with chronic diarrhea, periorbital ecchymosis, and hemolacria is described. Laboratory studies, biopsy, and immunohistochemical analysis were performed to confirm the diagnosis. The dependent variable was the confirmed diagnosis of AL amyloidosis, while the independent variables included clinical symptoms and diagnostic test results. Descriptive techniques were used to analyze the clinical and laboratory data. The patient presented with chronic diarrhea unresponsive to conventional treatment, periorbital ecchymosis, and hemolacria. Diagnostic studies revealed amyloid deposits in the tissues. Immunohistochemical analysis confirmed systemic light chain AL amyloidosis. Specific treatment was initiated, partially improving the symptoms and stabilizing the patient's condition. Systemic AL amyloidosis requires a high index of clinical suspicion for timely diagnosis. The combination of diagnostic studies and early treatment can improve the prognosis of these patients.
- Open Access
- 8 June 2023
- Published by Sociedad Peruana de Oncología Médica del Perú in ONKORESEARCH
- Vol. 2 (1) , 6-10
A case report of pleuropulmonary blastoma: a challenging diagnostic and therapeutic path in pediatrics
3-year-old female with a history of bullectomy at the age of 1-year-old, presented a course of progressive respiratory difficulty, dry cough and fever. Extension studies showed a solid tumor that covered almost the entire right hemithorax, displacing the mediastinum. An upper right lobectomy and lumpectomy were performed but a residual mass remained after surgery. Pleuropulmonary blastoma (PPB) type II-III with DICER 1 germinal mutation was diagnosed. She received the IVADo regimen, reducing the tumor size; however, the remaining residual tumor was inoperable. Consequently, she proceeded with a maintenance phase using the Vinorelbine/Cyclophosphamide regimen, being both regimens part of the non-standardized RMS-2005 protocol. A biopsy of the residual mass reported non evidence of cancer. After a 2-year follow-up, she remains cancer-free. This is a very rare disease lacking a standardized treatment protocol until now. It is associated with a genetic basis in 40% of it cases, linked to DICER1 mutation, and typically manifests within the first five years of life. The multidisciplinary management is key in this disease that can improve improves survival.
- 8 June 2023
- Published by Sociedad Peruana de Oncología Médica del Perú in ONKORESEARCH
- Vol. 2 (1) , 6-10
Open AccessA case report of pleuropulmonary blastoma: a challenging diagnostic and therapeutic path in pediatrics
3-year-old female with a history of bullectomy at the age of 1-year-old, presented a course of progressive respiratory difficulty, dry cough and fever. Extension studies showed a solid tumor that covered almost the entire right hemithorax, displacing the mediastinum. An upper right lobectomy and lumpectomy were performed but a residual mass remained after surgery. Pleuropulmonary blastoma (PPB) type II-III with DICER 1 germinal mutation was diagnosed. She received the IVADo regimen, reducing the tumor size; however, the remaining residual tumor was inoperable. Consequently, she proceeded with a maintenance phase using the Vinorelbine/Cyclophosphamide regimen, being both regimens part of the non-standardized RMS-2005 protocol. A biopsy of the residual mass reported non evidence of cancer. After a 2-year follow-up, she remains cancer-free. This is a very rare disease lacking a standardized treatment protocol until now. It is associated with a genetic basis in 40% of it cases, linked to DICER1 mutation, and typically manifests within the first five years of life. The multidisciplinary management is key in this disease that can improve improves survival.
- Open Access
- 1 December 2022
- Published by Elmer Press, Inc. in Journal of Endocrinology and Metabolism
- Vol. 12 (6) , 198-201
Mediastinal Mass as First Clinical Manifestation of Medullary Thyroid Microcarcinoma in a Patient With Hashimoto’s Thyroiditis
Medullary thyroid cancer is a rare neuroendocrine tumor with aggressive behavior and an uncertain prognosis. Calcitonin is the associated tumor marker; however, neuroendocrine tumors of the lung or intestine can also present high values. We report the case of a 53-year-old patient presenting with dry cough for 3 years. Computed tomography (CT) showed a 58-mm expansive lesion in the right anterior mediastinum and cervical ultrasound informed a 9-mm hypoechoic nodule with a lobulated edge and thick calcifications. Cytology reported Hashimoto’s thyroiditis. He underwent emergent surgery for respiratory failure. The pathological study informed G2 neuroendocrine carcinoma, immunohistochemistry showed: cytokeratin (+), vimentin (+), alpha-actin (-), synaptophysin (+), chromogranin (+), Ki-67: 10%. He progressed with bone metastasis visualized in scintigraphy and mediastinal tumor remnants, adenopathy, and pulmonary nodules on CT scan, prompting chemotherapy. Due to elevated and increasing calcitonin, an ultrasound study with needle washout for calcitonin resulted in 1,724 pg/mL, and cytology of the nodule reported medullary carcinoma. He was finally diagnosed with medullary thyroid microcarcinoma with metastasis to the mediastinum. Coexistence with Hashimoto’s thyroiditis could alter the initial fine-needle aspiration results. We conclude that in the case of calcitonin-secreting neuroendocrine tumors or medullary thyroid cancer, calcitonin fine needle aspirate washout may be helpful in elucidating a diagnosis. Due to its severity, medullary thyroid cancer should always be approached and managed aggressively, even microcarcinomas. J Endocrinol Metab. 2022;12(6):198-201 doi: https://doi.org/10.14740/jem841
- 1 December 2022
- Published by Elmer Press, Inc. in Journal of Endocrinology and Metabolism
- Vol. 12 (6) , 198-201
Open AccessMediastinal Mass as First Clinical Manifestation of Medullary Thyroid Microcarcinoma in a Patient With Hashimoto’s Thyroiditis
Medullary thyroid cancer is a rare neuroendocrine tumor with aggressive behavior and an uncertain prognosis. Calcitonin is the associated tumor marker; however, neuroendocrine tumors of the lung or intestine can also present high values. We report the case of a 53-year-old patient presenting with dry cough for 3 years. Computed tomography (CT) showed a 58-mm expansive lesion in the right anterior mediastinum and cervical ultrasound informed a 9-mm hypoechoic nodule with a lobulated edge and thick calcifications. Cytology reported Hashimoto’s thyroiditis. He underwent emergent surgery for respiratory failure. The pathological study informed G2 neuroendocrine carcinoma, immunohistochemistry showed: cytokeratin (+), vimentin (+), alpha-actin (-), synaptophysin (+), chromogranin (+), Ki-67: 10%. He progressed with bone metastasis visualized in scintigraphy and mediastinal tumor remnants, adenopathy, and pulmonary nodules on CT scan, prompting chemotherapy. Due to elevated and increasing calcitonin, an ultrasound study with needle washout for calcitonin resulted in 1,724 pg/mL, and cytology of the nodule reported medullary carcinoma. He was finally diagnosed with medullary thyroid microcarcinoma with metastasis to the mediastinum. Coexistence with Hashimoto’s thyroiditis could alter the initial fine-needle aspiration results. We conclude that in the case of calcitonin-secreting neuroendocrine tumors or medullary thyroid cancer, calcitonin fine needle aspirate washout may be helpful in elucidating a diagnosis. Due to its severity, medullary thyroid cancer should always be approached and managed aggressively, even microcarcinomas. J Endocrinol Metab. 2022;12(6):198-201 doi: https://doi.org/10.14740/jem841
- Open Access
- 12 October 2022
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 22 (4) , 878-881
Gastric Adenomyoma in adult a case report.
Objective: Report the clinical case of Gastric Adenomyoma as etiology of pyloric syndrome. Clinical case: We present a 52 years old man who attended the emergency room due pyloric syndrome and who underwent a distal gastrectomy. The pathological report revealed a gastric adenomyoma with ulcerative lesion. Discussion: This pathology is an unusual finding, and the literature describe it with extremely low rate of malignant transformation. Conclusion: Gastric adenomyoma is a infrequent pathology and should be taken into account when endoscopic studies are not enough to determine the etiology of a pyloric syndrome.
- 12 October 2022
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 22 (4) , 878-881
Open AccessGastric Adenomyoma in adult a case report.
Objective: Report the clinical case of Gastric Adenomyoma as etiology of pyloric syndrome. Clinical case: We present a 52 years old man who attended the emergency room due pyloric syndrome and who underwent a distal gastrectomy. The pathological report revealed a gastric adenomyoma with ulcerative lesion. Discussion: This pathology is an unusual finding, and the literature describe it with extremely low rate of malignant transformation. Conclusion: Gastric adenomyoma is a infrequent pathology and should be taken into account when endoscopic studies are not enough to determine the etiology of a pyloric syndrome.